aid: orasis-pharmaceuticals
name: Orasis Pharmaceuticals
description: >-
  Orasis Pharmaceuticals is an ophthalmic pharmaceutical company with offices in the United States
  and Israel, focused on treatments for presbyopia — the age-related loss of near vision that affects
  roughly two billion people worldwide. Its lead product, QLOSI (pilocarpine hydrochloride ophthalmic
  solution) 0.4%, is a preservative-free, single-use-vial prescription eye drop approved by the FDA in
  October 2023 and commercially available in the United States, with a follow-on candidate (BESKA)
  submitted for approval in Australia. The company is backed by life-sciences investors including
  Sequoia Capital, Johnson & Johnson Innovation and Arboretum Ventures. Orasis sells a regulated
  pharmaceutical product, not software: it operates a corporate marketing site plus product sites for
  patients (qlosi.com) and eye care professionals (qlosiecp.com), and publishes no developer program,
  public API, SDK, webhook surface or machine-readable API contract of any kind.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
image: https://orasis-pharma.com/hubfs/HQ%20Only/Orasis_Pharmaceuticals_Logo_RGB.svg
url: https://raw.githubusercontent.com/api-evangelist/orasis-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pass-completed
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Pharmaceuticals
- Life Sciences
- Ophthalmology
- Healthcare
- Vision
- Presbyopia
- Biotechnology
- Israel
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://orasis-pharma.com/
- type: About
  url: https://orasis-pharma.com/about
- type: Support
  url: https://orasis-pharma.com/contact
- type: Blog
  url: https://orasis-pharma.com/press-releases
- type: TermsOfService
  url: https://orasis-pharma.com/terms-of-service
- type: PrivacyPolicy
  url: https://orasis-pharma.com/privacy-policy
- type: DomainSecurity
  url: security/orasis-pharmaceuticals-domain-security.yml
- type: LLMsTxt
  url: llms/orasis-pharmaceuticals-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Orasis Pharmaceuticals is a commercial-stage ophthalmic drug maker whose product is a
    prescription eye drop (QLOSI); its three HubSpot-hosted sites carry no /developers, /api or
    /docs section at all, and every contract-discovery path probed on orasis-pharma.com,
    qlosi.com and qlosiecp.com returned the CMS 404 page.
  evidence:
  - url: https://orasis-pharma.com/openapi.json
    status: 404
  - url: https://orasis-pharma.com/api-docs
    status: 404
  - url: https://orasis-pharma.com/.well-known/api-catalog
    status: 404
  - url: https://qlosi.com/.well-known/agent-card.json
    status: 404
  - url: https://orasis-pharma.com/sitemap.xml
    status: 200
  checked: '2026-08-26'